General Archive

  • A child sits playing with a toy rocket, holding a nebuliser to their face

    Funding: CF AMR Syndicate funding call for new cystic fibrosis therapies

    Funding: CF AMR Syndicate funding call for new cystic fibrosis therapies LifeArc, as part of the CF AMR Syndicate, is…

    Read more

  • Female LifeArc Scientist pipettes liquid into a vial under a fume hood.

    Funding: Drug repurposing call to treat chronic respiratory infection

    Funding: Drug repurposing call to treat chronic respiratory infection LifeArc has committed £10m to fund up to five consortia programmes…

    Read more

  • News releases

    LifeArc’s Edinburgh labs featured in STV segment about innovations for people living with bronchiectasis

    Recently, our team had the pleasure of hosting STV for an exciting feature at the BioQuarter campus in Edinburgh. Watch…

    Read more

  • News releases

    NHS trial uses artificial intelligence to predict severe infections and transform lives of people living with chronic lung conditions

    A new NHS trial is using a home monitoring app combined with artificial intelligence (AI) to predict when people living…

    Read more

  • Microscopic view of lung tissue with congestion as shown by the red blood cells in the walls of the alveoli. Pneumonia.
    News releases

    LifeArc & Cystic Fibrosis Trust announce new £15m research funding to fast track treatment of lung infections

    Focussing on innovative approaches to improve quality of life for people with cystic fibrosis (CF)

    Read more

  • LifeArc scientist selecting samples in orange-capped vials from a grey, multi-well plate for testing.
    News releases

    LifeArc plans two major funding calls to boost translational research in rare disease & lung health in cystic fibrosis

    The calls are part of our wider £100m programme to support scientific innovation for people living with cystic fibrosis.

    Read more

  • News releases

    £3m fund to accelerate development of new CF therapies

    Collaborative funding to drug discovery innovators to accelerate new treatments for people with cystic fibrosis.

    Read more

  • Woman uses a nebulizer at home.
    News releases

    LifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis

    Three-year partnership to improve healthcare for thousands of people across Europe living with bronchiectasis.

    Read more

  • Person using nebulizer and inhaler for the treatment
    News releases

    LifeArc announces £10m funding call for new chronic respiratory infection therapies

    First major funding call announced as part of our £100m Chronic Respiratory Infection Translational Challenge

    Read more

  • Microscopic view of lung tissue with congestion as shown by the red blood cells in the walls of the alveoli. Pneumonia.
    News releases

    £100m programme to transform care for people living with chronic lung conditions

    More than 300,000 people in the UK are living with bronchiectasis and more than 10,000 have been diagnosed with cystic…

    Read more

  • Sammie Read, who has a chronic respiratory infection, with the at-home monitoring equipment.
    News releases

    LifeArc funds home monitoring trials for people with chronic respiratory conditions

    Trials will examine the impact of home monitoring and machine learning decision support algorithms for people with CF and bronchiectasis.

    Read more

  • Articles & blogs, Ventures funding

    AbbVie acquires LifeArc portfolio company DJS Antibodies

    AbbVie will pay DJS shareholders approximately $255 million in cash at closing for the acquisition of DJS

    Read more